Who Me, a Snob?

It's a common enough situation that Keith Weaver describes at Nature: at a conference, there are a number of talks scheduled at the same time, and you have to choose which to go to. And sometimes that choice is driven by not the title of the talks, but from what institutions the speakers hail.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.